Aterian, Inc.

NasdaqCM:ATER Voorraadrapport

Marktkapitalisatie: US$18.9m

Aterian Toekomstige groei

Future criteriumcontroles 0/6

De verwachting is dat Aterian de winst en omzet met respectievelijk 18.1% en 1.1% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 23.2% per jaar.

Belangrijke informatie

18.1%

Groei van de winst

23.2%

Groei van de winst per aandeel

Consumer Durables winstgroei9.0%
Inkomstengroei1.1%
Toekomstig rendement op eigen vermogenn/a
Dekking van analisten

Low

Laatst bijgewerkt12 Nov 2024

Recente toekomstige groei-updates

Analysts Have Been Trimming Their Aterian, Inc. (NASDAQ:ATER) Price Target After Its Latest Report

Nov 15
Analysts Have Been Trimming Their Aterian, Inc. (NASDAQ:ATER) Price Target After Its Latest Report

Aterian, Inc. (NASDAQ:ATER) Just Reported, And Analysts Assigned A US$9.67 Price Target

Aug 11
Aterian, Inc. (NASDAQ:ATER) Just Reported, And Analysts Assigned A US$9.67 Price Target

Recent updates

Analysts Have Been Trimming Their Aterian, Inc. (NASDAQ:ATER) Price Target After Its Latest Report

Nov 15
Analysts Have Been Trimming Their Aterian, Inc. (NASDAQ:ATER) Price Target After Its Latest Report

Is Aterian (NASDAQ:ATER) A Risky Investment?

Oct 15
Is Aterian (NASDAQ:ATER) A Risky Investment?

Aterian, Inc. (NASDAQ:ATER) Just Reported, And Analysts Assigned A US$9.67 Price Target

Aug 11
Aterian, Inc. (NASDAQ:ATER) Just Reported, And Analysts Assigned A US$9.67 Price Target

Aterian, Inc. (NASDAQ:ATER) Surges 42% Yet Its Low P/S Is No Reason For Excitement

Jul 17
Aterian, Inc. (NASDAQ:ATER) Surges 42% Yet Its Low P/S Is No Reason For Excitement

Aterian, Inc.'s (NASDAQ:ATER) Share Price Boosted 30% But Its Business Prospects Need A Lift Too

May 14
Aterian, Inc.'s (NASDAQ:ATER) Share Price Boosted 30% But Its Business Prospects Need A Lift Too

Does Aterian (NASDAQ:ATER) Have A Healthy Balance Sheet?

May 09
Does Aterian (NASDAQ:ATER) Have A Healthy Balance Sheet?

Aterian, Inc. (NASDAQ:ATER) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Feb 27
Aterian, Inc. (NASDAQ:ATER) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Does Aterian (NASDAQ:ATER) Have A Healthy Balance Sheet?

Oct 12
Does Aterian (NASDAQ:ATER) Have A Healthy Balance Sheet?

Things Look Grim For Aterian, Inc. (NASDAQ:ATER) After Today's Downgrade

Aug 14
Things Look Grim For Aterian, Inc. (NASDAQ:ATER) After Today's Downgrade

Is Aterian (NASDAQ:ATER) Weighed On By Its Debt Load?

May 13
Is Aterian (NASDAQ:ATER) Weighed On By Its Debt Load?

Analysts Have Been Trimming Their Aterian, Inc. (NASDAQ:ATER) Price Target After Its Latest Report

Mar 12
Analysts Have Been Trimming Their Aterian, Inc. (NASDAQ:ATER) Price Target After Its Latest Report

Are Investors Undervaluing Aterian, Inc. (NASDAQ:ATER) By 46%?

Jan 18
Are Investors Undervaluing Aterian, Inc. (NASDAQ:ATER) By 46%?

Aterian gains on guiding Q3 net revenue range above the consensus; resumes M&A strategy

Sep 30

Aterian's Silver Lining

Aug 22

Estimating The Fair Value Of Aterian, Inc. (NASDAQ:ATER)

Aug 17
Estimating The Fair Value Of Aterian, Inc. (NASDAQ:ATER)

Aterian GAAP EPS of -$0.26 misses by $0.08, revenue of $58.27M misses by $1.34M

Aug 08

Is Aterian (NASDAQ:ATER) Using Too Much Debt?

Jul 28
Is Aterian (NASDAQ:ATER) Using Too Much Debt?

Should You Think About Buying Aterian, Inc. (NASDAQ:ATER) Now?

Jul 08
Should You Think About Buying Aterian, Inc. (NASDAQ:ATER) Now?

Winst- en omzetgroeiprognoses

NasdaqCM:ATER - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/2026108-12N/AN/A1
12/31/2025103-13-4-43
12/31/202498-14-1-13
9/30/2024107-18-3-3N/A
6/30/2024121-23-2-2N/A
3/31/2024128-54-6-6N/A
12/31/2023143-75-14-13N/A
9/30/2023165-87-7-6N/A
6/30/2023191-198-4-4N/A
3/31/2023214-179-12-12N/A
12/31/2022221-196-18-17N/A
9/30/2022230-183-21-21N/A
6/30/2022231-176-31-31N/A
3/31/2022241-196-47-47N/A
12/31/2021248-236-42-42N/A
9/30/2021226-274-42-42N/A
6/30/2021217-164-18-18N/A
3/31/2021208-1311515N/A
12/31/2020186-6366N/A
9/30/2020170-37-5-4N/A
6/30/2020152-51-18-18N/A
3/31/2020122-65-30-30N/A
12/31/2019114-59-25-25N/A
9/30/2019109-49-24-24N/A
6/30/201993-39-29-29N/A
3/31/201977-31-33-33N/A
12/31/201873-32-30-30N/A
12/31/201736-23N/A-29N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachting is dat ATER de komende 3 jaar verliesgevend zal blijven.

Winst versus markt: De verwachting is dat ATER de komende 3 jaar verliesgevend zal blijven.

Hoge groeiwinsten: De verwachting is dat ATER de komende 3 jaar verliesgevend zal blijven.

Omzet versus markt: De omzet van ATER ( 1.1% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.9% per jaar).

Hoge groei-inkomsten: De omzet van ATER ( 1.1% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van ATER naar verwachting over 3 jaar hoog zal zijn


Ontdek groeibedrijven